Status:
COMPLETED
Use of iFOBT in Patients Presenting With Alarm Symptoms of Colorectal Cancer
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Regionshospitalet Horsens
Randers Regional Hospital
Conditions:
Colorectal Neoplasms
Colorectal Cancer
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
Background: Colorectal cancer (CRC) is one of the most common types of cancer in Denmark, and mortality among patients is high. Patients presenting with alarm symptoms of CRC are referred to colonosco...
Detailed Description
Background: Colorectal cancer (CRC) is among the most frequent types of cancer in Denmark with 5,015 incident cases in 2015 (3,455 colon cancer and 1,560 rectal cancer), and an average annual number o...
Eligibility Criteria
Inclusion
- Referred by a GP in the Central Denmark Region to colonoscopy in the cancer patient pathway for colorectal cancer.
Exclusion
- Referred to colonoscopy in the cancer patient pathway due to non-alarm symptoms.
Key Trial Info
Start Date :
March 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
1258 Patients enrolled
Trial Details
Trial ID
NCT03367611
Start Date
March 15 2018
End Date
December 31 2019
Last Update
March 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regionshospitalet Horsens
Horsens, Denmark